Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions

NCT05540288 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05540288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05540288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
March 31, 2023
Completion date
July 31, 2027
Enrollment
266 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

behavioural addiction